Akèy › Obèsite › Florid › Hialeah
Etid klinik pou Obèsite nan Hialeah, FL
13 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Hialeah (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Ap rekriteFaz 2
- AGA Clinical Trials, Hialeah
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Ap rekriteFaz 3
- Miguel Rebollar PA, Hialeah
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Elite Cardiac Research Center LLC, Hialeah
- Elite Clinical Research, Hialeah
- Panax Clinical Research, Miami Lakes · 4 mi lwen
- ak 2 plis
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mi lwen
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- Elite Cardiac Research Center LLC, Hialeah
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mi lwen
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- NeoClinical Research, Hialeah
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Indago Research and Health Center, Miami Lakes · 4 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- San Marcus Research Clinic Inc, Miami Lakes · 4 mi lwen
- Indago Research and Health Center, Miami Lakes · 4 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Miami Lakes · 4 mi lwen
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Aga Clinical Trials, Hialeah
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- Inpatient Research Clinic LLC, Miami Lakes · 4 mi lwen
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Ap rekriteFaz 3
- Angels Clinical Research Institute, Miami Lakes · 4 mi lwen
Etid Obèsite nan lòt vil
- Houston, TX44 etid
- Chicago, IL42 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Dallas, TX31 etid
- Orlando, FL31 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Atlanta, GA25 etid
- Jacksonville, FL25 etid
Lòt etid nan Hialeah
- Skizofreni13 etid
- Ensifizyans kadyak12 etid
- Sipwa10 etid
- Dyabèt Tip 210 etid
- Maladi fwa steatotik9 etid
- BPCO8 etid
- Ateroskleroz8 etid
- Twoub depresif majè8 etid
- Kondisyon Post-COVID (Long COVID)6 etid
- Maladi kadyovaskilè6 etid
- Kansè (tout kalite)6 etid
- Maladi Alzheimer6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.